Roderike Pohl,Nandini Kashyap,Robert Hauser,Koray Ozhan,Solomon S. Steiner
申请号：
US12778719
公开号：
US08637458B2
申请日:
2010.05.12
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A basal insulin formulation composed of insulin, preferably insulin glargine, injectable zinc and injectable iron compounds as precipitating and/or stabilizing agents has been developed for subcutaneous, intradermal or intramuscular administration. The formulation is designed to form a precipitate of insulin following injection, creating a slow releasing “basal insulin” over a period of 12 to 24 hours.
